Robotic thyroid surgery using bilateral axillo-breast approach: From a trainees' point of view by Gyan Chand, Jin Wook Yi, Goonj Johri

“…Results: Post-operative outcomes were excellent with lesser pain, better cosmesis and similar oncological outcomes in carefully selected thyroid cancers in comparison to conventional thyroidectomy. …”
Get full text

VARIABILITY AND microRNA EXPRESSION LEVEL IN TISSUES OF HEAD AND NECK TUMORS by Е. G. Nikitina, L. N. Urazova, О. V. Cheremisina, D. Е. Kulbakin, S. N. Stegniy

“…The panel of miR-200a, -200c, -21 and -205 was shown to be specific for determining the two locations (laryngeal and thyroid cancers) and probably can be used to define the site of a secondary tumor and / or metastasis of unknown origin.…”
Get full text

Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms by Ana Luiza Maia, Carla V. Ferreira, Mírian Romitti, Lucieli Ceolin, Débora R. Siqueira

“…It accounts for 5 to 8% of all thyroid cancers. MTC develops in either sporadic (75%) or hereditary form (25%). …”
Get full text

Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology—A Pilot Study by Aleksandra Kuzan, Emilia Królewicz, Karolina Nowakowska, Kamilla Stach, Krzysztof Kaliszewski, Paweł Domosławski, Łukasz Kotyra, Andrzej Gamian, Irena Kustrzeba-Wójcicka

“…The study samples were comprised of blood sera, thyroid, and adipose tissue sections probed from 37 patients diagnosed with thyroid cancers and goiter. Using immuno-enzymatic and fluorometric assays we analyzed the content of advanced glycation end-products (AGEs), pentosidine, receptors for advanced glycation end-products (RAGE), scavenger receptor class (SR)-A, SR-B, glutathione, malondialdehyde and nitric oxide synthase. …”
Get full text

Development of Functional Thyroid C Cell-like Cells from Human Pluripotent Cells in 2D and in 3D Scaffolds by Kwaku Dad Abu-Bonsrah, Donald F. Newgreen, Mirella Dottori

“…Medullary thyroid carcinoma contributes to about 3–4% of thyroid cancers and affects C cells rather than follicular cells. …”
Get full text

Role of Sostdc1 in skeletal biology and cancer by Xiaoyang Tong, Chenyu Zhu, Lifei Liu, Mei Huang, Jiake Xu, Xi Chen, Jun Zou

“…Recently, Sostdc1 has been found to be closely related to the development and progression of multiple cancer types, including breast, renal, gastric, and thyroid cancers. This article summarises the role of Sostdc1 in skeletal biology and related cancers to provide a theoretical basis for the treatment of related diseases.…”
Get full text

Drug therapy for hereditary cancers by Imyanitov Evgeny N, Moiseyenko Vladimir M

“…Hereditary medullary thyroid cancers (MTC) have been shown to be highly responsive to a multitargeted tyrosine kinase inhibitor vandetanib, which exerts specific activity towards mutated RET receptor. …”
Get full text

Nitroxides as Antioxidants and Anticancer Drugs by Marcin Lewandowski, Krzysztof Gwozdzinski

“…The application of nitroxides and their derivatives as anticancer drugs is discussed in the contexts of breast, hepatic, lung, ovarian, lymphatic and thyroid cancers under in vivo and in vitro experiments. …”
Get full text

Progress of molecular targeted therapy for head and neck cancer in clinical aspects by Kenji Nakano

“…New targeted therapies for non-squamous cell carcinoma patients were recently reported, e.g., tyrosine kinase inhibitors for the treatment of thyroid cancers and HER2-targeted therapy for salivary gland cancers. …”
Get full text

The molecular pathology of thyroid neoplasms by JB Thapa

“…Rapid advances have been made in the understanding of the genetics of thyroid cancers. Common genetic mutations include RAS, BRAF, p53, B Catenin, and PAX8/PPARγ, genes. …”
Get full text

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells by Mina Noura, Hidemasa Matsuo, Asami Koyama, Souichi Adachi, Hiroshi Masutani

“…Thioredoxin‐interacting protein (TXNIP) has been widely recognized as a tumor suppressor in various cancers, including liver, breast, and thyroid cancers. Although TXNIP is epigenetically silenced in acute myeloid leukemia (AML) cells, as in many cancer cells, its role in leukemogenesis remains elusive. …”
Get full text

Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy by Elena I. Fomchenko, James C. Bayley, Christopher Alvarez-Breckenridge, Laurence D. Rhines, Claudio E. Tatsui

“…This manuscript represents a narrative overview of novel targeted molecular therapies, chemotherapies, and immunotherapy treatments for patients with breast, lung, melanoma, renal cell, prostate, and thyroid cancers, which resulted in improved responses compared to standard chemotherapy. …”
Get full text

Do Thyroid Nodule Volume and Multicentricity in Childhood Effective on Malignancy? by Kemal Ayengi&775;n, Veli Avcı

“…INTRODUCTION: Thyroid cancers are the most common endocrine tissue malignancies. …”
Get full text

Application of society of radiologists in ultrasound recommendations for fine needle aspiration of thyroid nodules by Poonam Agarwal, Silpa Kadiyala, V Suresh, Amith Chowhan, A Y Lakshmi, B Vijayalakshmi

“…Background: The Society of Radiologists in Ultrasound (SRU) recommendations on thyroid nodules are intended to ”diagnose thyroid cancers that have reached clinical significance,while avoiding unnecessary tests and surgery in patients with benign nodules.” …”
Get full text

Endocrine Disorders in Children with Brain Tumors: At Diagnosis, after Surgery, Radiotherapy and Chemotherapy by Fabien Claude, Graziamaria Ubertini, Gabor Szinnai

“…Thyroid nodules or secondary thyroid cancers may arise years after radiotherapy. Gonadal dysfunction is frequent after chemotherapy especially with alkylating agents. …”
Get full text

Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer by Tsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Tzer-Ming Chuang, Yuh-Ching Gau, Shih-Feng Cho, Yi-Chang Liu, Hui-Hua Hsiao, Li-Tzong Chen, Mei-Ren Pan, Hui-Ching Wang, Sin-Hua Moi

“…Two major hotspot TERT promoter mutations (C228T and C250T) have been reported in different malignancies such as melanoma, genitourinary cancers, CNS tumors, hepatocellular carcinoma, thyroid cancers, sarcomas, and HNCs. The frequencies of TERT promoter mutations vary widely across tumors and is quite high in HNCs (11.9–64.7%). …”
Get full text

De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017 by Boyeon Kim, Minjin Kang, Yoonjung Kim, Hyung Soon Lee, Banseok Kim, Jung Jun Lee, Yongjung Park, Kyung-A Lee

“…Malignancies occurred in 7.6% of the total KT patients. Prostate and thyroid cancers were the most common in males and females, respectively. …”
Get full text

Case report: a grievous tale of a rare primary thyroid leiomyosarcoma by Wan Nabila Wan Mansor, Norhaslinda Abdul Gani, Khairul Azlan Shahril Abu Dahari, Aliza Ahmad, Rohaizam Japar Jaafar

“…Abstract Background Primary thyroid leiomysosarcoma is a rare and aggressive disease which represents 0.014% of primary thyroid cancers. It confers a diagnostic conundrum, due to difficulty to make a preoperative diagnosis of thyroid leiomyosarcoma and to differentiate it from anaplastic thyroid carcinoma. …”
Get full text

Berberine as a Potential Anticancer Agent: A Comprehensive Review by Abdur Rauf, Tareq Abu-Izneid, Anees Ahmed Khalil, Muhammad Imran, Zafar Ali Shah, Talha Bin Emran, Saikat Mitra, Zidan Khan, Fahad A. Alhumaydhi, Abdullah S. M. Aljohani, Ishaq Khan, Md. Mominur Rahman, Philippe Jeandet, Tanweer Aslam Gondal

“…The therapeutic efficacy of BBR has been reported in several studies regarding colon, breast, pancreatic, liver, oral, bone, cutaneous, prostate, intestine, and thyroid cancers. BBR prevents cancer cell proliferation by inducing apoptosis and controlling the cell cycle as well as autophagy. …”
Get full text

Study of various histopathological types of malignant lesions of Thyroid by K Rajakumar1 , Syed Mahmoodur Rahman2 , G Vandana3 , Sandhya Anil4

“…Background: Thyroid gland is unique among the endocrine glands in having a wide spectrum of diseases ranging from functional enlargements, immunologically mediated enlargements to neoplastic lesions .Thyroid cancers accounts for approximately 1% of all malignancies in developed countries with an estimated annual incidence of 122,000 cases worldwide. …”
Get full text